Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1631 1632
This examiner grants 38% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19300583 | HEAT SHOCK INDUCIBLE CELLS AND THEIR MANUFACTURE AND USE | Non-Final OA | Upside Foods, Inc. |
| 17229746 | COPPER LOSS MITIGATION | Non-Final OA | Genentech, Inc. |
| 17754848 | GENE TARGETS FOR MANIPULATING T CELL BEHAVIOR | Final Rejection | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY |
| 17112720 | METHOD FOR PRODUCING HUMAN A1 ASTROCYTES, HUMAN A1 ASTROCYTES, AND METHOD FOR EVALUATING TEST SUBSTANCE | Final Rejection | FUJIFILM Corporation |
| 17905748 | METHODS, COMPOUNDS, AND COMPOSITIONS FOR MODIFYING CAR-T CELL ACTIVITY | Non-Final OA | Purdue Research Foundation |
| 17433934 | METHOD FOR PRODUCING OSTEOBLAST CLUSTER USING IPS CELLS | Final Rejection | TOHOKU UNIVERSITY |
| 18260786 | COMPOSITIONS FOR TREATING FRIEDREICH'S ATAXIA | Non-Final OA | The Trustees of the University of Pennsylvania |
| 18566001 | NOVEL PLURIPOTENT CELLS | Non-Final OA | DAEGU GYEONGBUK INSTITUTE OF SCIENCE AND TECHNOLOGY |
| 17904487 | MAMMALIAN CELL CULTURE PROCESSES | Non-Final OA | Boehringer Ingelheim International GmbH |
| 18040345 | REDUCTION OF COVID-19 COAGULOPATHY AND OTHER INFLAMMATION-ASSOCIATED COAGULOPATHIES BY ADMINISTRATION OF FIBROBLASTS | Non-Final OA | FIGENE, LLC |
| 17905197 | GENERATION OF AUTOIMMUNE INHIBITORY T CELLS BY FIBROBLAST MEDIATED EDUCATION | Non-Final OA | FIGENE, LLC |
| 17071020 | Cell-Based Biosensor for Early Alzheimer's Disease Detection | Final Rejection | University of South Carolina |
| 17780658 | Methods of activating cytotoxic leukocytes using PTP1B and PTPN2 inhibitors | Non-Final OA | Peter MacCallum Cancer Institute |
| 17231278 | HUMAN INTESTINAL EPITHELIUM MODEL AND METHOD FOR PREPARING SAME | Non-Final OA | KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY |
| 18249469 | URINE-DERIVED EPITHELIAL CELL CULTURES, NEPHROSPHEROIDS DERIVED THEREFROM AND METHODS OF PRODUCING AND USING SAME | Non-Final OA | TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. |
| 17241648 | Methods for the Storage of Whole Blood, and Compositions Thereof | Non-Final OA | Hemanext Inc. |
| 16320531 | SIMULTANEOUS SEPARATION AND ACTIVATION OF T CELLS FROM BLOOD PRODUCTS WITH SUBSEQUENT STIMULATION TO EXPAND T CELLS | Non-Final OA | BIOMAGNETIC SOLUTIONS LLC |
| 17619108 | HETEROGENEOUS STEM CELL POPULATION, PREPARATION METHOD THEREFOR AND USE THEREOF | Final Rejection | INSTITUTE OF BASIC MEDICAL SCIENCES, CHINESE ACADEMY OF MEDICAL SCIENCES |
| 14124884 | CULTURE MEDIA FOR STEM CELLS | Final Rejection | KONINKLIJKE NEDERLANDSE AKADEMIE VAN WETENSCHAPPEN |
| 17055077 | FUSOSOME COMPOSITIONS AND USES THEREOF | Non-Final OA | FLAGSHIP PIONEERING INNOVATIONS V, INC. |
| 18000122 | SEED CELL MEDIUM OF TUMOR-INFILTRATING LYMPHOCYTE AND APPLICATION THEREOF | Non-Final OA | SHANGHAI JUNCELL THERAPEUTICS CO., LTD. |
| 17262400 | METHOD FOR PRODUCING FOREIGN ANTIGEN RECEPTOR GENE-INTRODUCED CELL | Non-Final OA | NATIONAL UNIVERSITY CORPORATION SHIGA UNIVERSITY OF MEDICAL SCIENCE |
| 18041487 | METHOD FOR PRODUCING TUMOR-INFILTRATING T-LYMPHOCYTES (TIL) AND THEIR USE AS CELLULAR THERAPEUTICS FOR THE TREATMENT OF HUMAN TUMORS | Non-Final OA | ZELLWERK GMBH |
| 16083372 | DOUBLE TUBULAR STRUCTURES | Non-Final OA | MIMETAS B.V. |
| 18009799 | PRODUCTION OF XENOGRAFT FROM ANIMAL BONES | Non-Final OA | YILDIZ TEKNIK UNIVERSITESI |
| 17052841 | DE-DIFFERENTIATED FIBROBLAST-CONDITIONED MEDIA FOR STIMULATION OF DISC REGENERATION | Non-Final OA | SpinalCyte, LLC |
| 17768274 | COMPOUNDS FOR IMMUNOMODULATION | Non-Final OA | FUNDACIÓ INSTITUT D'INVESTIGACIÓ BIOMÈDICA DE BELLVITGE (IDIBELL) |
| 17629918 | ADOPTIVE TRANSFER OF PLASMACYTOID DENDRITIC CELLS TO PREVENT OR TREAT HAIR LOSS | Final Rejection | Tufts Medical Center, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy